PB2100: REAL‐WORLD TREATMENT PATTERNS OF TRIPLE‐CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A RETROSPECTIVE CHART STUDY
Guillaume, Xavier, Horchi, Dahbia, Gomez, Jorge, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P957: AN INDIRECT COMPARISON OF ELRANATAMAB’S (ELRA) OBJECTIVE RESPONSE RATE (ORR) FROM MAGNETISMM‐3 (MM‐3) VERSUS REAL‐WORLD EXTERNAL CONTROL ARMS IN TRIPLE‐CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM)
Costa, Luciano, Leblanc, Thomas W, Tesch, Hans, Sonneveld, Pieter, Kyle, Ryan, Sinyavskaya, Liliya, Hlavacek, Patrick, Meche, Aster, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P924: TREATMENT PATTERNS OF TRIPLE‐CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL‐WORLD OBSERVATIONAL CHART REVIEW STUDY
Goyal, Ravi K, Frugier, Gaelle, Rombi, Julien, Esterberg, Lizzi, Davis, Keith, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Real-world treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A retrospective chart study
Guillaume, Xavier, Horchi, Dahbia, Gomez, Jorge, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, DiBonaventura, Marco
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma
Mol, Isha, Hu, Yannan, LeBlanc, Thomas W, Cappelleri, Joseph C, Chu, Haitao, Nador, Guido, Aydin, Didem, Schepart, Alex, Hlavacek, Patrick
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab and Teclistamab in Patients with Triple-Class Exposed/Refractory Multiple Myeloma
Mol, Isha, Hu, Yannan, LeBlanc, Thomas W, Cappelleri, Joseph C, Chu, Haitao, Nador, Guido, Aydin, Didem, Schepart, Alex, Hlavacek, Patrick
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma
Costa, Luciano, LeBlanc, Thomas W, Tesch, Hans, Sonneveld, Pieter, Kyle, Ryan, Sinyavskaya, Liliya, Hlavacek, Patrick, Meche, Aster, Ren, Jinma, Schepart, Alex, Aydin, Didem, Nador, Guido, DiBonaventura, Marco
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
An indirect comparison of elranatamab’s (ELRA) objective response rate (ORR) from MagnetisMM-3 (MM-3) vs real-world external control arms in triple-class refractory (TCR) multiple myeloma (MM)
Costa, Luciano J., LeBlanc, Thomas William, Tesch, Hans, Sonneveld, Pieter, Kyle, Ryan, Sinyavskaya, Liliya, Hlavacek, Patrick, Meche, Aster, Ren, Jinma, Schepart, Alex, Aydin, Didem, DiBonaventura, Marco
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A real-world observational chart review study
Goyal, Ravi K., Frugier, Gaelle, Rombi, Julien, Esterberg, Lizzi, Davis, Keith L., Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, DiBonaventura, Marco
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma
Mol, Isha, Hu, Yannan, LeBlanc, Thomas W, Cappelleri, Joseph C, Chu, Haitao, Nador, Guido, Aydin, Didem, Schepart, Alex, Hlavacek, Patrick
Published in Current medical research and opinion (01.02.2024)
Published in Current medical research and opinion (01.02.2024)
Get more information
Journal Article
Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data
Sinyavskaya, Liliya, Meche, Aster, Faucher, Ariane, Hlavacek, Patrick, Johnson, Sarasa M A, DiBonaventura, Marco, Vekeman, Francis, Ren, Jinma, Schepart, Alex
Published in Current medical research and opinion (03.05.2024)
Published in Current medical research and opinion (03.05.2024)
Get more information
Journal Article
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma
Mol, Isha, Hu, Yannan, LeBlanc, Thomas W, Cappelleri, Joseph C, Chu, Haitao, Nador, Guido, Aydin, Didem, Schepart, Alex, Hlavacek, Patrick
Published in Leukemia & lymphoma (01.05.2024)
Published in Leukemia & lymphoma (01.05.2024)
Get more information
Journal Article
Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study
Charalampous, Charalampos, Kumar, Shaji Kunnathu, Parrondo, Ricardo, Chhabra, Saurabh, Duh, Mei Sheng, Bobbili, Priyanka, Wang, Aolin, Chen, Jingyi, Mohan, Manasi, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Nador, Guido, DiBonaventura, Marco
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Medicare characteristics, treatment, cost and survival in triple class exposed relapsed or refractory multiple myeloma
Hlavacek, Patrick, Schepart, Alex, Silverstein, Alison R, Petrilla, Allison A, Johnson, William, Schroeder, Amy
Published in Future oncology (London, England) (01.04.2023)
Published in Future oncology (London, England) (01.04.2023)
Get full text
Journal Article
Abstract 12703: Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure and Performance of an Adapted Wild-Type ATTR-CM Machine Learning Model: Findings From GWTG-HF
Peters, Anthony, Solomon, Nicole, Chiswell, Karen, Fonarow, Gregg C, Khouri, Michel G, Schepart, Alex, Baylor, Lori, Alvir, Jose, Bruno, Marianna, Huda, Ahsan, Allen, Larry A, Sharma, Kavita, Devore, Adam D, Greene, Stephen J
Published in Circulation (New York, N.Y.) (08.11.2022)
Published in Circulation (New York, N.Y.) (08.11.2022)
Get full text
Journal Article
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma
Costa, Luciano J, LeBlanc, Thomas W, Tesch, Hans, Sonneveld, Pieter, Kyle, Ryan P, Sinyavskaya, Liliya, Hlavacek, Patrick, Meche, Aster, Ren, Jinma, Schepart, Alex, Aydin, Didem, Nador, Guido, DiBonaventura, Marco daCosta
Published in Future oncology (London, England) (2024)
Published in Future oncology (London, England) (2024)
Get full text
Journal Article